Emril Ali Email & Phone Number

Parkville, Vic, Au

Melbourne, Victoria, Au

Industry and Business Development Engagement for the School of Chemical and BiomedicalEngineering.

Murarrie, Queensland, Au

• Provide independent advice and feedback to company’s business development strategy. • Structuring of company management team and operations efficiency and strategic direction

Hercules, Ca, Us

• Sales management and support of Bio-Rad’s Droplet Digital PCR System • Engagement with BioPharma & Biotech Accounts • Achieved and exceeded target within first year with 11% growth in Q4 2021• Exceeded BioPharma Sales Target with more than 30% growth in 2022

Waltham, Ma, Us

• Maintain key partnership support to Thermo Fisher’s high-profile Biopharmaceutical CSL Group • Sales and business target management of territory. • Achieved over $6M Sales Target with over 5% growth within first year • 6 Consecutive quarters above AOP Sales Target • Part of Vaccine Production Cross Business A3 Project to promote inter-team collaboration

Startup with Presence in Australia and Singapore, targeted focus on Epilepsy Management• Seek partnership and investment opportunities• Manage company financials and oversee key affairs in Singapore• Coordinated potential key investor and development partners for NIESM in Singapore.

Singapore, Sg

Melbourne-based Market Access Operation, of Zicom Investment Group (ZIG) Ventures:Spin-off from Zicom Group (ASX: ZGL)Sabbatical from Zicom Group in April 2018 to Feb 2019• Lead and manage Australian Market Access Team• Develop and implement go-to market adoption and strategies for ZIG’s Portfolio Companies i. Biobot Surgicals Pte Ltd: MRI-Ultrasound Robotic Guided Prostate Cancer Biopsy ii. Histoindex Pte Ltd: Automated Non-Staining Multiphoton Tissue Imaging System• Promote the early adoption and sales of newly developed novel medical technologies • Facilitate engagement with strategic Australian research partners, clinicians and investment groups• C-Suite, Clinical KOL engagements with hospitals to negotiate sales and partnership• Achieved targeted $1M revenue in overall Australia MedTech Group sales (First FY 2016/2-17) • Established 6 Key Strategic Hospital Reference sites for Biobot Surgicals Pte Ltd • Facilitated Multi-Centre, Robotic Prostate Cancer Biopsy Study in QLD, VIC, and SA. • Established 2 Key Customer and Pre-Clinical Adoption sites for Histoindex Pte Ltd

Victoria, 3800, Au

• Implement strategic industry engagement models for the schools and research institutions• Manage, facilitate, negotiate and secure industry contract research• Engagement of faculty with external government and private funding partners• Point of contact and advisor to researchers seeking industry and government partners• Negotiated and secured a 3-year $350,000 industry funded project • Facilitated a 3-year collaboration with CSIRO to further develop commercial applications of Ephrin A1

Singapore, Singapore, Sg

• Licensing, Commercialization, and IP management of A*STAR Diagnostic Technology Portfolio. • Strategize development plan for various key technology portfolio based on industry inputs. • Evaluate and identify high potential technology assets to be proposed for further development projects • Established the National Diagnostics Development (DxD) Hub Program with ISO13485 • DxD Hub went to raise over S$30M in Industry funding with over 20 products launched over 5 years• Negotiated multi-million-dollar licensing and development partnership• Successfully managed a 3-year, S$2M MicroRNA Diagnostics project to completion• Further expansion project to a 5-year, S$12M Program Multi-disease Program. • Established microRNA screening facility in partnership Thermo Fisher Scientific (Life Technologies)• Pioneer miRNA Project of Program: miRNA Blood based Gastric Cancer Test (GASTROClear)• GASTROClear approved for IVD in 2020 and FDA in 2023 (IFU with Thermofisher’s QS 5 System). • Collaboration engagement with Multi-National Companies on development of MicroRNA diagnostics• Structured technology licensing and spun off 2 medical device diagnostics startups. i. Baldr Biosystems Pte Ltd: Small Form Factor RT-PCR System ii. MiRXES Pte Ltd: miRNA based Molecular Diagnostics Platform • Incubated and managed MiRXES project, prior 2014 spinoff • MiRXES subsequently went through the following fund raising:- Series B US$40M investment via VC after merger in 2018- Series C US$77M in 2021- Series D US$50M in 2023.

Singapore, Sg

Project leader of IBN MicroKit, a 2009 award-winning portable, automated device for sample preparation and disease diagnosis. MicroKit won "Best Innovation in Biomedical and Pharmaceutical Applications" Award at the 2009 ASEAN Virtual Instrumentation Applications Contest organized by National Instruments.Successfully integrated Real-time PCR with a fully automated sample extraction system.Collaborated with NUH molecular diagnosis laboratory to establish real-time PCR protocols to be incorporated into IBN's automated diagnostic system.Spearheaded a series of further development projects to increase the potential applications of IBN's existing automated diagnostic system, utilizing mini DNA arrays and lateral flow and membrane array platforms to improve the system's cost competiveness.Speaker at various platforms including IBN conferences, science fairs and school talks.

Singapore, Sg

Investigated the potential use of ZnO nanocrystals as a fluorescence based sensor to detect biomolecules with aldehyde functional groups.Developed and investigated the potential use of Glutathione Capped Quantum Dots in the detection of lead ions in waterEstablished the potential of utilizing charge manipulation to perturb the onset potential of Polyethylenediothiophene (PEDOT) conducting polymer for biosensing applicationsIntegrated PEDOT nanowires with fabricated micro electrodes, via "Top-Up" approach, for "Label-Free" DNA detectionResponsibilitiesOrganized the layout and setup the necessary research equipments for Biosensor TeamSafety, chemical consumable purchase and maintenance of laboratorySupervise student projects under the IBN's Youth Research Program

Singapore, Sg

Investigated the potential of integrating navigation and tactile sensors to 'Minimally Invasive' surgical devices and tools to aid surgeons and minimize the use of X-ray imaging during surgery.Liaised with surgeons and clinicians from NUH to discuss methods to improve the usability of existing medical devices.Organized the layout and setup the necessary laboratory equipments in Anechoic chamber for Hearing Research.Responsible for the safety, chemical consumable purchase and maintenance of laboratory.

Taught Biology and Mathematics to students with varying learning capabilities ranging from Normal Technical to Express Streams.

Auburn Hills, Michigan, Us

• Supported engineering team with bench test validation studies for Variable Cam Timing System • Researched and analyzed the mechanical schematics of existing VCT systems in competing units• VCT system was eventually implemented in mid-2000 production vehicles (Ford, GM)

Msc (Distinction), Engineering And Physical Science In Medicine

Phd, Integrative Sciences And Engineering

Beng (Hons), Mechanical Engineering

A' Levels, Biology, Chemistry, Physics, Mathematics

O' Level